Capha Pharmaceuticals Inc. filed its Annual on Apr 29, 2022 for the period ending Dec 31, 2021. In this report its auditor, Dyke & Howard - D & H Group LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 64 | |
+31.07% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+14.79% | 239B | |
+10.18% | 210B | |
-6.95% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- FPSUF Stock
- News Capha Pharmaceuticals Inc.
- Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt